Braslyn Ltd.

CIK 1642355 · last filed 2024-01-25

Braslyn Ltd. is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2016. Across all open-market trades the lifetime net is −$228.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions. The firm reports its address in New Providence, C5. 11 SEC filings were submitted jointly with JOSEPH LEWIS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.23M

Companies

3

Total Filings

22

Lifetime Open-Market Net

-$228.18M

Filer Profile

Reported Address
ALBANY FINANCIAL CENTER, SUITE 207
LEWIS DRIVE N7776
NEW PROVIDENCE, C5 00000
Phone
(407) 909-9970
Related Filers
JOSEPH LEWIS — 11 joint filings, latest 2024-01-25
Boxer Capital, LLC — 9 joint filings, latest 2024-01-25
Boxer Asset Management Inc. — 7 joint filings, latest 2024-01-25
MVA Investors, LLC — 7 joint filings, latest 2024-01-25
Aaron I. Davis — 4 joint filings, latest 2024-01-25
Shehan Bharatha Dissanayake — 2 joint filings, latest 2024-01-25
Christopher Fuglesang — 2 joint filings, latest 2024-01-25
RODNEY W LAPPE — 1 joint filings, latest 2017-10-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Mirati Therapeutics, Inc. (MRTX) Delisted 10%+ Owner 3,135,557 $58.70 $184.06M -$269.37M 19 2021-03-10
INSG 10%+ Owner 761,483 $4.24 $3.23M -$36.81M 1 2020-12-16
Pandion Therapeutics, Inc. (PAND) Delisted 10%+ Owner 1,408,913 $60.05 $84.61M $78.00M 1 2020-07-21

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-01-25 Disp (D) −61,735,896 $0
2021-03-10 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed -$4.89M EDGAR
2020-12-16 INSG Sell (S) −2,385,170 -$36.81M EDGAR
2020-10-30 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed -$166.67M EDGAR
2020-07-21 Pandion Therapeutics, Inc. (PAND) Delisted Mixed +12,786,810 $78.00M EDGAR
2020-06-16 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed -$58.20M EDGAR
2020-06-16 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed -$41.40M EDGAR
2019-03-05 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed -$18.98M EDGAR
2017-11-20 Mirati Therapeutics, Inc. (MRTX) Delisted Buy (P) +800,000 $10.40M EDGAR
2017-01-30 Mirati Therapeutics, Inc. (MRTX) Delisted Buy (P) +48,169 $262.3K EDGAR
Showing 110 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.